These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4325139)

  • 1. [Effect of a tetracosactide with depot action in the asthmatic syndrome].
    Illig H
    Med Klin; 1970 May; 65(20):985-7. PubMed ID: 4325139
    [No Abstract]   [Full Text] [Related]  

  • 2. [Synthetic depot-ACTH, plasmacortisol levels, and asthmatic syndrome (author's transl)].
    Illig H; Giesen HK
    Med Klin; 1975 Feb; 70(9):377-9. PubMed ID: 164616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A synthetic polypeptide--beta 1-24 corticotropin--in the depot form. II. Clinical efficacy of intermittent therapy in asthmatic patients.
    Benos SA; Koutsoukos A; Sotirakis I; Pavlatos FC
    Acta Allergol; 1969 Sep; 24(3):178-86. PubMed ID: 4314190
    [No Abstract]   [Full Text] [Related]  

  • 4. [Beta 1-24 corticotrophin or tetracosactide in asthma and allergic diseases].
    Wolfromm R; Herman D
    Therapeutique; 1969 Feb; 45(2):131-46. PubMed ID: 4320666
    [No Abstract]   [Full Text] [Related]  

  • 5. Corticotrophin and its synthetic analogues.
    Br Med J; 1969 Jun; 2(5660):809-11. PubMed ID: 4306559
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tetracosactide in the treatment of asthma].
    Bartsch P
    Acta Tuberc Pneumol Belg; 1970; 61(3):277-85. PubMed ID: 4324499
    [No Abstract]   [Full Text] [Related]  

  • 7. [Melanoderma as a side effect of cortisone depot therapy].
    Rainova R; Kaloianov K
    Vutr Boles; 1974; 13(2):120-2. PubMed ID: 4370659
    [No Abstract]   [Full Text] [Related]  

  • 8. [Synacthen-depot treatment during withdrawal of long-term corticotherapy in patients with asthma].
    Obtulowicz K; Glowacka A
    Pol Tyg Lek; 1974 Apr; 29(13):519-22. PubMed ID: 4363174
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hypersensitivity to synthetic ACTH (Synacthen) in patients with bronchial asthma].
    Obtulowicz K; Glowacka A
    Pol Tyg Lek; 1974 Mar; 29(12):473-4. PubMed ID: 4362422
    [No Abstract]   [Full Text] [Related]  

  • 10. [The use of sequence 1-39 human synthetic ACTH in therapy of asthmatic syndromes].
    Pozzi E; Scala C
    Clin Ter; 1980 May; 93(3):319-27. PubMed ID: 6256122
    [No Abstract]   [Full Text] [Related]  

  • 11. [Current status of treatment with a synthetic corticotropic peptide, tetracosactide-retard].
    Deguillaume R
    Presse Med (1893); 1971 Jan; 79(6):233-5. PubMed ID: 4323028
    [No Abstract]   [Full Text] [Related]  

  • 12. [Place of a delayed-action tetracosactide (synthetic cortico-stimulant) in treatment of obstructive bronchopathy].
    Uzzan D; Israel-Asselain R
    J Fr Med Chir Thorac; 1969; 23(5):561-72. PubMed ID: 4323669
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hypophysoadrenal effects of prolonged corticotherapy in small doses in asthmatic patients].
    Magnenat G; Cruchaud S; Ruedi B
    Schweiz Med Wochenschr; 1972 Jun; 102(23):804-9. PubMed ID: 4338343
    [No Abstract]   [Full Text] [Related]  

  • 14. [Synthetic ACTH: therapeutic application].
    Kumagai A; Ishii Z; Nakasawa R
    Nihon Rinsho; 1971 Jul; 29(7):1775-81. PubMed ID: 4338287
    [No Abstract]   [Full Text] [Related]  

  • 15. [Depot-ACTH in the ambulatory management of obstructive bronchial diseases].
    Frank A
    Wien Med Wochenschr; 1968 Mar; 118(12):253-6. PubMed ID: 4301963
    [No Abstract]   [Full Text] [Related]  

  • 16. [The steroid-sparing effect of disodium cromoglycate in chronic asthma].
    Spitzer SA
    Harefuah; 1971 Aug; 81(3):130-4. PubMed ID: 4333951
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term treatment with corticosteroids and ACTH in asthmatic children. I. A pulmonary function study with re-investigation after 5 years.
    Oberger E; Engström I
    Eur J Respir Dis; 1981 Aug; 62(4):256-67. PubMed ID: 6273203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A.C.T.H. treatment and its effect on serum cortisol in asthmatic adults].
    Herman D; Dry J
    Therapie; 1973; 28(5):1003-11. PubMed ID: 4368043
    [No Abstract]   [Full Text] [Related]  

  • 19. [Synthetic depot-ACTH in the treatment of obstructive bronchial diseases].
    Frank A
    Wien Med Wochenschr; 1971 Nov; 121(47):844-8. PubMed ID: 4331890
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of bronchial asthma using a synthetic beta 1-18 corticotropin derivative].
    Walser A; Keller R; Herzog H
    Schweiz Med Wochenschr; 1969 Nov; 99(48):1726-8. PubMed ID: 4312242
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.